AntiDepressant Warning Expanded Print E-mail
Wednesday, 02 May 2007
5.2.07 - Young adults beginning treatment with antidepressants should be warned about an increased risk of suicidal thoughts and behavior, federal health officials said Wednesday.  The proposed label changes would apply to all antidepressants, including Lexapro (Forest Laboratories Inc.), Paxil (GlaxoSmithKline PLC), Prozac (Eli Lilly and Co.) and Zoloft (Pfizer Inc.). Some of the drugs are available in generic form as well. The expanded warning would apply to adults 18-24 during the first month or two of treatment with the drugs, the FDA said.
 
< Prev   Next >